Evidence map›Paper›PMID 24867069›Full record

Trial reportDiabetic medicine : a journal of the British Diabetic Association2014

Effect of oral nutritional supplementation on wound healing in diabetic foot ulcers: a prospective randomized controlled trial.

D G Armstrong, J R Hanft, V R Driver, A P S Smith, J L Lazaro-Martinez, A M Reyzelman, G J Furst, D J Vayser, H L Cervantes, R J Snyder and 6 more

2 registry-linked trialsOpen access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Diabetic medicine : a journal of the British Diabetic Association, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 38 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 5 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03782155 phase4unknown statusnot on this mapstarted 2021, after this paper: background citation

Effect of Supplementation With b- Hydroxy Methyl Butyrate and Glutamine in Wound Healing Histology in Type 2 Diabetes and Controls Bloody Areas

TypeinterventionalSponsorHospital General de MexicoRan2021 to 2021Enrolled30ConditionsWound Healing, DiabeticArmsglutamine supplementation, HMB, Placebo
NCT05243368 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Evaluation of Personalized Nutritional Intervention Together With the Application of MSC-derived Exosomes on the Regenerative Capacity and Wound Healing of Cutaneous Ulcers in Diabetics

TypeinterventionalSponsorMaimónides Biomedical Research Institute of CórdobaRan2023 to 2024Enrolled30ConditionsFoot, DiabeticArmsPersonalized Nutritional Intervention
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 5 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Nutritional interventions for treating foot ulcers in people with diabetes.The Cochrane database of systematic reviews · 2020
    Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Diabetic wounds and short-chain fatty acids.Journal of diabetes and metabolic disorders · 2025
    Review
  13. Review
  14. HMB/Arg/Gln may improve short-term outcomes after esophagectomy in patients with thoracic esophageal cancer.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 2 countries.

D G ArmstrongSouthern Arizona Limb Salvage Alliance (SALSA), Department of Surgery, University of Arizona College of Medicine, Tucson, AZ.
J R Hanft
V R Driver
A P S Smith
J L Lazaro-Martinez
A M Reyzelman
G J Furst
D J Vayser
H L Cervantes
R J Snyder
M F Moore
P E May
J L Nelson
G E Baggs
A C Voss
Diabetic Foot Nutrition Study Group
Abbott (United States) · USAbbott Nutrition (United States)Boston University · USCenter for Clinical Research (United States) · USFlorida Hospital Medical Group · USResearch Network (United States) · USUniversidad Complutense de Madrid · ESUniversity of Arizona · USVA Sierra Nevada Health Care System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsAmong people with diabetes, 10-25% will experience a foot ulcer. Research has shown that supplementation with arginine, glutamine and β-hydroxy-β-methylbutyrate may improve wound repair. This study tested whether such supplementation would improve healing of foot ulcers in persons with diabetes.

methodsAlong with standard of care, 270 subjects received, in a double-blinded fashion, (twice per day) either arginine, glutamine and β-hydroxy-β-methylbutyrate or a control drink for 16 weeks. The proportion of subjects with total wound closure and time to complete healing was assessed. In a post-hoc analysis, the interaction of serum albumin or limb perfusion, as measured by ankle-brachial index, and supplementation on healing was investigated.

resultsOverall, there were no group differences in wound closure or time to wound healing at week 16. However, in subjects with an albumin level of ≤ 40 g/l and/or an ankle-brachial index of < 1.0, a significantly greater proportion of subjects in the arginine, glutamine and β-hydroxy-β-methylbutyrate group healed at week 16 compared with control subjects (P = 0.03 and 0.008, respectively). Those with low albumin or decreased limb perfusion in the supplementation group were 1.70 (95% CI 1.04-2.79) and 1.66 (95% CI 1.15-2.38) times more likely to heal.

conclusionsWhile no differences in healing were identified with supplementation in non-ischaemic patients or those with normal albumin, addition of arginine, glutamine and β-hydroxy-β-methylbutyrate as an adjunct to standard of care may improve healing of diabetic foot ulcers in patients with risk of poor limb perfusion and/or low albumin levels. Further investigation involving arginine, glutamine and β-hydroxy-β-methylbutyrate in these high-risk subgroups might prove clinically valuable.

Indexed as

Dietary SupplementsWound HealingAdultAgedAged, 80 and overAnkle Brachial IndexArginineDiabetic FootDouble-Blind MethodFemaleGlutamineHumansMaleMiddle AgedProspective StudiesTreatment OutcomeArgininebeta-hydroxyisovaleric acidGlutamineValerates

Identifiers

PMID24867069
PMCPMC4232867
OpenAlexW2056275276

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.